Induction of HSP70 gene expression by modulation of Ca+2 ion and cellular p53 protein by curcumin in colorectal carcinoma cells

Molecular Carcinogenesis

Volumn 17, Issue 4, 1996, Pages 224-234

  Chen, Yen Chou ^a   Kuo, Tsun Cheng ^a   Lin Shiau, Shoei Yn ^a   Lin, Jen Kun ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Ca+2; Curcumin; HSP70; p53

Indexed keywords

CALCIMYCIN; CALCIUM; CURCUMIN; ENDONUCLEASE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; METHYLMERCURY; PROTEIN P53; VERAPAMIL;

ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; APOPTOSIS; CALCIMYCIN; CALCIUM; CALCIUM CHANNEL BLOCKERS; CARCINOGENS; CURCUMIN; DEOXYRIBONUCLEASE I; DNA, NEOPLASM; DNA-BINDING PROTEINS; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HSP70 HEAT-SHOCK PROTEINS; HT29 CELLS; HUMANS; IONOPHORES; METHYLMERCURY COMPOUNDS; MICE; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; VERAPAMIL;

CURCUMA LONGA;

EID: 0030476104     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2744(199612)17:4<224::aid-mc6>3.0.co;2-d     Document Type: Article

References (51)

1. Kerr JFR, Searle J, Harmon BV, Bishop CJ. Apoptosis. In: Potten CS (ed), Perspectives on Mammalian Cell Death. Oxford University Press, Oxford, 1987, pp. 93-128.
2. Dive C, Hickman JA. Drug-target interactions: Only the first step in the commitment to a programmed cell death? Br J Cancer 64:192-196, 1991.
3. Gunji H, Kharbanda S, Kufe D. Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-β-D-arabinofuranosylcytosine. Cancer Res 51:741-743, 1991.
4. Cotter TG, Glynn JM, Echeverri F, Green DR. The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle. Anticancer Res 12:773-780, 1992.
5. Barry MA, Behnke CA, Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 40:2353-2362, 1990.
6. Takano YS, Harmon BV, Kerr JFR. Apoptosis induced by mild hyperthermia in human and murine tumor cell lines: A study using electron microscopy and DNA gel electrophoresis. J Pathol 163:329-336, 1991.
7. Kyprianou N, English HF, Davidson NE, Isaacs JT. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 51:162-166, 1991.
8. Redding TW, Schally AV, Radulovic S, Milovanovic S, Szepeshazi K, Isaacs JT. Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice. Cancer Res 52:2538-2544, 1992.
9. Wyllie AH. The biology of cell death in tumors. Anticancer Res 5:131-136, 1985.
10. Wyllie AH, Rose KA, Morris RG, Steel CM, Foster E, Spandidos DA. Rodent fibroblast tumors expressing human myc and ras genes: Growth, metastasis and endogenous oncogene expression. Br J Cancer 56:251-259, 1987.
11. Srimal RC, Dhawan BN. Pharmacology of diferuloyl methane (curcumin), non-steroidal anti-inflammatory agent. J Pharm Pharmacol 25:447-452, 1973.
12. Rao CV, Rivenson A, Simi B, Reddy BS. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55:259-266, 1995.
13. Huang MT, Lou Y-R, Ma W, Newmark HL, Reuhl KR, Conney AH. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 54:5841-5847, 1994.
14. Huang HC, Jan TR, Yeh SF. Inhibitory effect of curcumin, an anti-inflammatory agent, on vascular smooth muscle cell proliferation. Eur J Pharmacol 221:381-384, 1992.
15. Kprutla L, Cheung JY, Mendelsohn J, Kumar R. Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis 16:1741-1745, 1995.
16. Huang TS, Lee SC, Lin JK. Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc Natl Acad Sci USA 88:5292-5296, 1991.
17. Lu YP, Chang RL, Huang MT, Conney AH. Inhibitory effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced increase in ornithine decarboxylase mRNA in mouse epidermis. Carcinogenesis 14:293-297, 1993.
18. Liu JY, Lin SJ, Lin JK. Inhibitory effects of curcumin on protein kinases C activity induced by 12-O-tetradecanoylphorbol-13-acetate in NIH3T3 cells. Carcinogenesis 14:857-861, 1993.
19. Tisser A, Mitchell HK, Tracy U. Protein synthesis in salivary glands of Drosophila melanogaster. Relation to chromosome puffs. J Mol Biol 84:389-398, 1974.
20. Peluso RW, Lamb RA, Choppin PW. Polypeptide synthesis in simian virus 5-infected cells. J Virol 23:177-187, 1977.
21. Li GC. Induction of thermotolerance and enhanced heat shock protein synthesis in Chinese hamster fibroblasts by sodium arsenite and by ethanol. J Cell Physiol 115:116-122, 1983
22. Hightower LE. Heat shock, stress proteins, chaperones and proteotoxicity. Cell 66:191-197, 1991.
23. Hollstein M, Sidransky D, Vogelstein B. p53 mutations in human cancers. Science 253:49-53, 1991.
24. Levine CC, Momand CA, Finlay CA. The p53 tumour suppressor gene. Nature 351:453, 1991.
25. Ginsberg D, Mechta F, Yaniv M, Oren M. Wild-type p53 can down modulate the activity of various promoters. Proc Natl Acad Sci USA 88:9979, 1991.
26. Agoff SN, Hou J, Linzer DIH, Wu B. Regulation of the human hsp70 promoter by p53. Science 259:84-87, 1993.
27. McConkey DJ, Hartzell P, Orrenius S. Rapid turnover of endogenous endonucleases activity in thymocytes: Effects of inhibitors of macromolecular synthesis. Arch Biochem Biophys 278:284-287, 1990.
28. Stokke T, Erikstein B, Smedshammer L, Boye E, Steen HB. The retinoblastoma gene product is bound in the nucleus in the early G1 phase. Exp Cell Res 240:147-155, 1993.
29. Ho YS, Wang YJ, Lin JK. Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol Carcinog 16:20-31, 1996.
30. Mosser DD, Theodorakis NG, Morimoto RI. Coordinate changes in heat shock element binding activity and hsp70 gene transcription rates in human cells. Mol Cell Biol 8:4736-4744, 1988.
31. Scharff O, Foder B Thastrup O, et al. Effect of thapsigargin on cytoplasmatic Ca and proliferation of human lymphocytes in relation to AIDS. Biochim Biophys Acta 972:257-264, 1988.
32. Gurney AM. Measurement and control of intracellular calcium. In: Hulme EC (ed), Receptor-Effector Coupling. A Practical Approach. IRL Press, Oxford, 1985, pp. 117-154.
33. +2 indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450, 1985.
34. Liu RY, Corry PM, Lee YJ. Potential involvement of a constitutive heat shock element binding factor in the regulation of chemical stress-induced hsp70 gene expression. Mol Cell Biol 144:27-34, 1995.
35. +2-ATPase inhibitor thapsigargin. J Biol Chem 268:12003-12009, 1993.
36. Chen YC, Lin JK. Photodynamic anticancer agent merocyanine540 inhibits cell growth by apoptosis. Anticancer Res, in press.
37. Liu RY, Kim D, Yang SH, Li GC. Dual control of heat shock response: Involvement of a constitutive heat shock element-binding factor. Proc Natl Acad Sci USA 90:3078-3082, 1993.
38. +2-dependent endonuclease from human spleen: Purification properties and role in apoptosis. Biochemistry 32:9129-9136, 1993.
39. Barry MA, Eastman A. Identification of deoxyribonuclease II as an endonuclease involved in apoptosis. Biochim Biophys Acta 300:440-450, 1993.
40. Peterson R, Lindquist S. The Drosophila hsp70 message is rapidly degraded at normal temperature and stabilized by heat shock. Gene 72:161-168, 1988.
41. Pelham HRP. A regulatory upsystem promoter element in the Drosophila hsp70 heat-shock gene. Cell 30:517-528, 1982.
42. Hensold JO, Hunt CR, Calderwood SK, Housman DE, Kingston RE. DNA binding of heat shock factor to the heat element is insufficient for transcriptional activation in murine erythroleukemia cells. Mol Cell Biol 10:1600-1608, 1990.
43. Wooten MW. Alterations in protein kinase C type III-α during heat shock of rat embryo fibroblast. Exp Cell Res 193:274-278, 1991.
44. Kern SE. Identification of p53 as a sequence-specific DNA binding protein. Science 252:1708, 1991.
45. Field S, Jang SK. Presence of a potent transcription activating sequence in the p53 protein. Science 249:1046, 1990.
46. Park DJ, Nakamura H, Chumakov AM, et al. Transactivation and DNA binding abilities of endogenous p53 in mutant cell lines. Oncogene 9:1899-1906, 1994.
47. Dulic V, Kaufmann WK, Wilson SJ, et al. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013-1023, 1994.
48. Russo T, Zambrano N, Esposito F, et al. A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress. J Biol Chem 270:29386-29391, 1995.
49. Slichenmyer WJ, Nelson WG, Slebos RJ, Kastan MB. Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res 53:4164-4168, 1993
50. Lin JK, Shih CA. Inhibitory effect of curcumin on xanthine dehydrogenase/oxidase induced by phorbol-12-myristate-13-acetate in NIH3T3. Carcinogenesis 15:1717-1721, 1994.
51. Lin JK, Lee SF. Inhibition of tumor promotion through blocking signal transduction. Zoological Studies 34:67-81, 1995.